Back to Market Feed

EMGALITY 300 MG DOSE (100 MG/ML X 3 SYRINGES)

galcanezumab-gnlm
$612.1410per ML

Strength

100 mg/mL

NDC

00002311509

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

GALCANEZUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761063

On Market Since

6/4/2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+2.7%

3Y

+12.1%

5Y

+21.4%

All

+32.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

No related drugs found.